MichelAzizi Université Paris Cité, Hypertension department, HôFrance

• Michel Azizi (born april 4, 1958) is Professor of Vascular Medicine at Université Paris Cité and Head of the Hypertension Unit and of the Clinical Investigation Center, Georges Pompidou University Hospital, Paris, France. • He received his MD from René Descartes University and his PhD from Pierre et Marie Curie University, Paris, France. • He is past member of the Clinical Research Commission of the INSERM, in France. He is currently member of the Research Commission of Université Paris Cité, France. • He is past Vice-President of the European Society of Hypertension. He is currently President of the WG on “Adherence, pharmacotherapy and lifestyle” of the European Society of Hypertension. • His main research interests include the medication- and device-based treatment of resistant hypertension, adherence to treatment and the physiology, genetics and pharmacology of the renin–angiotensin–aldosterone system. • He has published more than 300 papers in peer reviewed journals, many of which have focused on the renin-angiotensin-system, resistant hypertension and renal denervation. • He has received the Jean Hamburger prize for Medical Research in 2007, the University of Paris Scientific Award in 2009, 2013, 2017 and 2021 Paris, France, the Peter van Zwieten award of the European Society of Hypertension in 2011, Milan, Italy, the Scientific award of the Italian Society of Hypertension in 2013, the Scientific award of the Portuguese Society of Hypertension in 2016, the Paul Milliez award at the European Society of Hypertension in 2017, The 2019 Research prize of the magazine “La Recherche” Paris, France; the Award of the French National Academy of Medicine in 2022. • He is Board member of the French Society of Hypertension and the European Society of Hypertension. He is member of the French Society of Cardiology, and the European Society of Cardiology.